{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:29:43Z","timestamp":1791041383793,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.jconrel.2006.06.014","type":"journal-article","created":{"date-parts":[[2006,6,18]],"date-time":"2006-06-18T11:21:00Z","timestamp":1150629660000},"page":"175-183","source":"Crossref","is-referenced-by-count":71,"title":["Polymeric conjugates of mono- and bi-cyclic \u03b1V\u03b23 binding peptides for tumor targeting"],"prefix":"10.1016","volume":"114","author":[{"given":"Amitava","family":"Mitra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomika","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Borgman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjan","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Ghandehari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Line","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2006.06.014_bib1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.7512751","article-title":"Requirement of vascular integrin alpha v beta 3 for angiogenesis","volume":"264","author":"Brooks","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2006.06.014_bib2","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1126\/science.270.5241.1500","article-title":"Definition of two angiogenic pathways by distinct alpha v integrins","volume":"270","author":"Friedlander","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2006.06.014_bib3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0092-8674(94)90007-8","article-title":"Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels","volume":"79","author":"Brooks","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2006.06.014_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.bjc.6601576","article-title":"Integrins: roles in cancer development and as treatment targets","volume":"90","author":"Jin","year":"2004","journal-title":"Br. J Cancer"},{"key":"10.1016\/j.jconrel.2006.06.014_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0070-2153(05)68007-6","article-title":"Assembly and signaling of adhesion complexes","volume":"68","author":"Sepulveda","year":"2005","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.jconrel.2006.06.014_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrc727","article-title":"Role of integrins in cell invasion and migration","volume":"2","author":"Hood","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2006.06.014_bib7","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1126\/science.285.5430.1028","article-title":"Integrin signaling","volume":"285","author":"Giancotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2006.06.014_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nbt0395-265","article-title":"Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins","volume":"13","author":"Koivunen","year":"1995","journal-title":"Biotechnology (N.Y.)"},{"key":"10.1016\/j.jconrel.2006.06.014_bib9","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1021\/bi002101f","article-title":"Solution structures and integrin binding activities of an RGD peptide with two isomers","volume":"40","author":"Assa-Munt","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2006.06.014_bib10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1034\/j.1399-3011.1999.00052.x","article-title":"Solution stability of linear vs. cyclic RGD peptides","volume":"53","author":"Bogdanowich-Knipp","year":"1999","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.jconrel.2006.06.014_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2004.09.023","article-title":"Targeting tumor angiogenic vasculature using polymer\u2013RGD conjugates","volume":"102","author":"Mitra","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.06.014_bib12","first-page":"1552","article-title":"Targeting tumor angiogenesis: comparison of peptide and polymer\u2013peptide conjugates","volume":"46","author":"Line","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2006.06.014_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nucmedbio.2005.09.005","article-title":"Polymer\u2013peptide conjugates for angiogenesis targeted tumor radiotherapy","volume":"33","author":"Mitra","year":"2006","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jconrel.2006.06.014_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1126\/science.279.5349.377","article-title":"Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model","volume":"279","author":"Arap","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2006.06.014_bib15","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/12469","article-title":"Anti-cancer activity of targeted pro-apoptotic peptides","volume":"5","author":"Ellerby","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2006.06.014_bib16","first-page":"1061","article-title":"Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting","volume":"40","author":"Haubner","year":"1999","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2006.06.014_bib17","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2174\/1381612043384745","article-title":"Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies","volume":"10","author":"Haubner","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2006.06.014_bib18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.drup.2005.10.002","article-title":"RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature","volume":"8","author":"Temming","year":"2005","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jconrel.2006.06.014_bib19","first-page":"326","article-title":"Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics","volume":"42","author":"Haubner","year":"2001","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2006.06.014_bib20","first-page":"1781","article-title":"Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography","volume":"61","author":"Haubner","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2006.06.014_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1021\/bc034170n","article-title":"[18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates","volume":"15","author":"Haubner","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2006.06.014_bib22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1089\/108497802320970244","article-title":"Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting","volume":"17","author":"Janssen","year":"2002","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.jconrel.2006.06.014_bib23","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.mibio.2004.06.004","article-title":"MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides","volume":"6","author":"Chen","year":"2004","journal-title":"Mol. Imaging Biol"},{"key":"10.1016\/j.jconrel.2006.06.014_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1162\/1535350041464892","article-title":"Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide","volume":"3","author":"Chen","year":"2004","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.jconrel.2006.06.014_bib25","first-page":"1707","article-title":"microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide","volume":"46","author":"Wu","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2006.06.014_bib26","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1021\/bc0501698","article-title":"Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice","volume":"16","author":"Cheng","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2006.06.014_bib27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0939-6411(00)00075-8","article-title":"HPMA copolymer\u2013anticancer drug conjugates: design, activity, and mechanism of action","volume":"50","author":"Kopecek","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2006.06.014_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/3540587888_14","article-title":"Polymer conjugates with anticancer activity","volume":"122","author":"Putnam","year":"1995","journal-title":"Adv. Polym. Sci."},{"key":"10.1016\/j.jconrel.2006.06.014_bib29","unstructured":"A. Mitra, A. Nan, B. R. Line, H. Ghandehari, Nanocarriers for nuclear imaging and radiotherapy of cancer. Curr. Pharm. Des. (in press)."},{"key":"10.1016\/j.jconrel.2006.06.014_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/apmc.1978.050700110","article-title":"Poly N-(2-hydroxypropyl) methacrylamide: 4. Heterogeneous polymerization","volume":"70","author":"Strohalm","year":"1978","journal-title":"Angew. Makromol. Chem."},{"key":"10.1016\/j.jconrel.2006.06.014_bib31","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/macp.1977.021780803","article-title":"Aminolyses of monomeric and polymeric p-nitrophenyl esters of methacryloylated amino acids","volume":"178","author":"Rejmanova","year":"1977","journal-title":"Makromol. Chem."},{"key":"10.1016\/j.jconrel.2006.06.014_bib32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0142-9612(90)90058-X","article-title":"Surface properties of copolymers of alkyl methacrylates with methoxy (polyethylene oxide) methacrylates and their application as protein-resistant coatings","volume":"11","author":"Lee","year":"1990","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2006.06.014_bib33","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/pola.1994.080320904","article-title":"Biodegradable and pH sensitive hydrogels. Synthesis by crosslinking of N,N-dimethylacrylamide copolymer precursors","volume":"32","author":"Yeh","year":"1994","journal-title":"J. Polym. Sci., A, Polym. Chem."},{"key":"10.1016\/j.jconrel.2006.06.014_bib34","first-page":"2834","article-title":"Preclinical evaluation of 111In-labeled B3 monoclonal antibody: biodistribution and imaging studies in nude mice bearing human epidermoid carcinoma xenografts","volume":"53","author":"Camera","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2006.06.014_bib35","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1002\/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3","article-title":"Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors","volume":"37","author":"Mammen","year":"1998","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.jconrel.2006.06.014_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jconrel.2005.09.010","article-title":"Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers","volume":"110","author":"Lammers","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.06.014_bib37","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1371\/journal.pmed.0020070","article-title":"Noninvasive Visualization of the Activated alphavbeta3 Integrin in Cancer Patients by Positron Emission Tomography and [(18)F]Galacto-RGD","volume":"2","author":"Haubner","year":"2005","journal-title":"PLoS.Med."},{"key":"10.1016\/j.jconrel.2006.06.014_bib38","first-page":"1333","article-title":"Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients","volume":"46","author":"Beer","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2006.06.014_bib39","first-page":"6146","article-title":"Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model","volume":"62","author":"Janssen","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2006.06.014_bib40","first-page":"1940","article-title":"Molecular targeting with peptides or peptide\u2013polymer conjugates: just a question of size?","volume":"46","author":"Wester","year":"2005","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2006.06.014_bib41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.06.014_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0168-3659(99)00113-3","article-title":"Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts","volume":"61","author":"Shiah","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2006.06.014_bib43","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/0959-8049(94)00514-6","article-title":"Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier","volume":"31A","author":"Seymour","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2006.06.014_bib44","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1023\/B:PHAM.0000033001.49737.b7","article-title":"Technetium-99m-labeled N-(2-hydroxypropyl) methacrylamide copolymers: synthesis, characterization, and in vivo biodistribution","volume":"21","author":"Mitra","year":"2004","journal-title":"Pharm. Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365906002483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365906002483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T16:50:35Z","timestamp":1547571035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365906002483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0168365906002483"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2006.06.014","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}